Literature DB >> 36253637

Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series.

Sara R Vazquez1,2, Aaron S Wilson3, Daniel M Witt3,4.   

Abstract

Entities:  

Year:  2022        PMID： 36253637      PMCID： PMC9579540          DOI： 10.1007/s11239-022-02707-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   5.221


× No keyword cloud information.
  4 in total

Review 1.  Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

Authors:  Sara R Vazquez
Journal:  Blood       Date:  2018-11-22       Impact factor: 22.113

2.  Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants.

Authors:  Nicholas W Lange; David M Salerno; Douglas L Jennings; Jason Choe; Jessica Hedvat; Danielle Bley Kovac; Jenna Scheffert; Tara Shertel; Lloyd E Ratner; Robert S Brown; Marcus R Pereira
Journal:  Am J Transplant       Date:  2022-01-19       Impact factor: 9.369

Review 3.  SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.

Authors:  Zeinab Mohseni Afshar; Mohammad Barary; Arefeh Babazadeh; Rezvan Hosseinzadeh; Amirmasoud Alijanpour; Seyed Rouhollah Miri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Florian Langer; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2022-02-03       Impact factor: 11.043

4.  Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.

Authors:  Felix Stader; Hannah Kinvig; Manuel Battegay; Saye Khoo; Andrew Owen; Marco Siccardi; Catia Marzolini
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.